JPRN-UMIN000016283已完成2 期
Effect of CTLA4-Ig on severe asthma (ECSA) study ; Double blind, placebo controlled, phase IIa trial of CTLA4-Ig (abatacept) on severe asthma - Effect of CTLA4-Ig on severe asthma (ECSA) study
ational Hospital Organization, Sagamihara National Hospital0 个研究点目标入组 30 人开始时间: 2015年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Administration of abatacept in the past. Rheumatoid arthritis. Respiratory disorders other than asthma. Current malignancy or past history of (within 5 years) malignancy. Other clinically serious health problems. Active infectious diseases or psoriasis. Those who are pregnant, under-lactation, or desire pregnancy. Administration of live vaccine within past 3 months or during the trial period or those who desire live vaccine within 3 months from the end of the trial. Omalizumab use within past 3 months. History or suspicion of alcohol or drug abuse within past 2 years. Enrollment in other clinical trials within past 3 months. Other conditions that doctors consider not eligible.
研究者
相似试验
尚未招募
Unknown
REsearch for Asthma and COPD exacerbaTION induced by SARS-CoV2 vaccination (REACTION Study)JPRN-UMIN000049011agoya City University Hospital Allergy and Clinical Immunology300
已完成
2 期
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes MellitusType 1 Diabetes MellitusNCT00505375National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)112
已完成
不适用
Effect of CTLA-4-Ig on human B lymphocyte function and specificity for citrullinated protein antigens in rheumatoid arthritis (RA)Rheumatoid ArthritisDRKS00012864niversitätsklinikum Freiburg10
已完成
不适用
Effect of plasmacluster on mild to moderate asthma in children: A randomazed double-blinded trialasthmaJPRN-UMIN000006354Public Health Research Foundation24
已完成
不适用
Effect of plasmacluster on mild to moderate asthma in children: A randomazed doubleblinded trialasthmaJPRN-UMIN000011589Clinical Research Support Center, The University of Tokyo Hospital130